Last reviewed · How we verify
H002 capsule
At a glance
| Generic name | H002 capsule |
|---|---|
| Also known as | H002 |
| Sponsor | RedCloud Bio |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation (PHASE1, PHASE2)
- H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- H002 capsule CI brief — competitive landscape report
- H002 capsule updates RSS · CI watch RSS
- RedCloud Bio portfolio CI